Integrative bioinformatics analysis and experimental validation of key biomarkers driving the progression of cirrhotic portal hypertension
OIT3 and LOXL1 were identified as potential novel targets for the diagnosis and treatment of cirrhotic portal hypertension (CPH).
Authors
- Peng Gu (ORCID: https://orcid.org/0000-0001-5641-960X)
- Meilin Li (ORCID: https://orcid.org/0000-0002-3675-5523)
- Zhonghua Lu
- Yi Ru (ORCID: https://orcid.org/0009-0004-0057-4108)
- Li-Lin Jiang
Institutions
- Jiangnan University (CN)
- Wuxi People's Hospital (CN)
Publication Details
- Journal
- PeerJ
- Published
- 2025-04-30
- DOI
- https://doi.org/10.7717/peerj.19360
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00